South Korea · Artificial Intelligence (AI) startup
South Korea · NEUROPHET
NEUROPHET is a medical SW company using advanced neuroscience and AI technologies for better brain treatment.
Funding reportedLast round: Series C
What company datasets say NEUROPHET raised
Funding, as reported
Reported in all48Bin the source's currency
Rounds6
Last roundSeries C
Last round dateNov 2023
Investors listed21
Artificial Intelligence (AI) in South Korea
Startups like it
Is this your company?
Add your raise, your deck and your story, and put NEUROPHET in front of investors. Or tell us what we have wrong.